1-(2-Ethoxybenzoyl)piperidin-4-amine hydrochloride, 95%, 50mg

(2-Methoxyphenyl)diphenylphosphine, 98%, 100mg

5-p-Tolyl[1,3,4]thiadiazol-2-ylamine, 95.0%, 25g

2-(3,5-Dichloro-4-methoxyphenyl)4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

Ethyl 2,4-Dimethylpyrrole-3-carboxylate>98.0%(GC)5g

E-Plan phase EPLPH 20x/0.40 objective. Working distance 1.85 mm

2,3-dihydrobenzo[g]quinolin-4(1H)-one, 95.0%, 250mg

(1R)-1-(3-METHOXYPHENYL)PROPYLAMINE, 95.0%, 1g

2-Methylisothiazolidine 1,1-dioxide, 95.0%, 5g

2-Chloro-5-fluoro-3-nitropyridine>98.0%(GC)200mg

2,2-Difluoro-2-(1-methyl-1H-imidazol-2-yl)acetic acid, lithium salt, 5g

6-Bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 250mg

Methyl 3-methyl-4-(methylamino)benzoate, 98%, 100mg